3Gibofsky A, Williams GW, McKenna F, et al. Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trial [J ]. Arthritis Rheum,2003,
4Reginster YJ, Deroisy R, Paul I, et al. Glucosamine Sulfate significantly reduces progression of knee OA over 3 years:a large randomized, place-controlled, double-blind prospective trial.Arthritis Rheum[J ]. 1999, 42: 28-33.
5American College of Rheumatology Subcommittce on Osteoarthritis.Recommendations for the medical management of osteoarthritis of the hip and knee[J ]. Arthritis Rheum, 2000, 43(9): 1905-1915.
6Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucossmine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial [ J ]. Lancet, 2001, 357(9252) :251-256.
7Balazs EA. Bloon G Fine structure and glrcosamininoslycan content of the surface layer of articular cartilage [ J ]. Fed Proc,1966, 25(6): 1813.
8Soeeken KL, Lee WL, Bausell RB, et al. Safety and efficacy of Sadenosylmethionine (SAME) for Osteoarthrits [ J ]. J Fam Pract, 2002, 51(5) :425.
9Blumenfeld I, Livne E. The role of transforming growth factor (TGF)-beta, insulin-like growth factor (IGF)-I, and interleukin ( IL-1 ) in osteoarthritis and aging of joints [ J ]. Exp Gerontol, 1999,34(7) :821.
10Brandt KD. Should ostcoarthrits be treated with nonsteroidal anti-inflammatory drugs [ J ]? Rheum Dis Clino North Am,1993, 19: 697-712.
